Reference
Plamadeala V, et al. A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian cancer. Gynecologic Oncology : 24 Nov 2014. Available from: URL: http://doi.org/10.1016/j.ygyno.2014.11.019
Rights and permissions
About this article
Cite this article
Chemoresponse assay proves its worth in ovarian cancer. PharmacoEcon Outcomes News 718, 16 (2014). https://doi.org/10.1007/s40274-014-1781-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1781-3